 Wall Street analysts predict that Mirum Pharmaceuticals NASDAQ:MIRM will post earnings per share of 0.81 for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Mirum Pharmaceuticals earnings, with estimates ranging from 0.86 to 0.76. The company is expected to report its next quarterly earnings report on Thursday, June ... 